Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease

By Björkqvist Maria   Petersén Åsa   Bacos Karl   Isaacs Jeremy   Norlén Per   Gil Joana   Popovic Natalija   Sundler Frank   Bates Gillian P.   Tabrizi Sarah J.   Brundin Patrik   Mulder Hindrik  

Human Molecular Genetics, Vol. 15, Iss. 10, 2006-05 ,pp. : 1713-1721

Oxford University Press

Access to resources Recommend Favorite

Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease

By Perry Giselle M.   Tallaksen-Greene Sara   Kumar Ashish   Heng Mary Y.   Kneynsberg Andrew   van Groen Thomas   Detloff Peter J.   Albin Roger L.   Lesort Mathieu  

Human Molecular Genetics, Vol. 19, Iss. 17, 2010-09 ,pp. : 3354-3371

Oxford University Press

Access to resources Recommend Favorite

Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease

By Pang Terence Y.C.   Du Xin   Zajac Michelle S.   Howard Monique L.   Hannan Anthony J.  

Human Molecular Genetics, Vol. 18, Iss. 4, 2009-02 ,pp. : 753-766

Oxford University Press

Access to resources Recommend Favorite

Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington’s disease mutation

By Fain J.N.  

Human Molecular Genetics, Vol. 10, Iss. 2, 2001-01 ,pp. : 145-152

Oxford University Press

Access to resources Recommend Favorite

Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington’s disease (HD) transgenic mice and HD patients

By Wanker E.E.  

Human Molecular Genetics, Vol. 10, Iss. 21, 2001-10 ,pp. : 2425-2435

Oxford University Press

Access to resources Recommend Favorite